GlassScriptPhysician profile
Vanessa Lambert Hill
NPI 1053634386
$11,278.23
in general payments reported to CMS, 2019-2025
10 companies · $441 in 2025
The $441 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $7,206 · 2022: $994 · 2023: $175 · 2024: $2,463 · 2025: $441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,450 · Food and Beverage: $1,224 · Travel and Lodging: $350 · Education: $54.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,450.00 |
| Food and Beverage | $1,223.69 |
| Travel and Lodging | $350.09 |
| Education | $54.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $5,195.75 | 2021-2022 | |
| Pfizer INC. | $2,143.92 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $2,065.09 | 2024 | Saphnelo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $825.00 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $618.89 | 2022-2025 | Cuvitru |
| Janssen Biotech, INC. | $237.44 | 2024-2025 | Tremfya |
| Janssen Scientific Affairs, LLC | $111.21 | 2024-2025 | Tremfya |
| Tonix Medicines, INC. | $42.86 | 2025 | Zembrace Symtouch |
| Regeneron Healthcare Solutions, INC. | $22.06 | 2025 | Dupixent |
| Genentech, INC. | $16.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vanessa Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.